Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid Arthritis

NCT06906549 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

260

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis (RA)
Rituximab (RTx)

Interventions

DRUG: Rituximab 200mg/6months
DRUG: Rituximab 1g/6months

Sponsor

University Hospital, Strasbourg, France